As quality standards are increasingly in demand throughout medicine, dermatology needs to
establish outcome measures to quantify the effectiveness of treatments and providers. The …

In the United States, access to care is the number one issue facing our patients with dermatological
conditions. In part, this is because we do not have outcome measures that are useful …

Psoriasis is one of the most prevalent and studied immune-mediated diseases and has
benefited from considerable recent advances in treatment, but it remains largely undertreated. …

… In this analysis, we used a combination of energy, activity and policy data available up to
the end of April 2020 to estimate the changes in daily emissions during the confinement from …

The Centers for Disease Control and Prevention (CDC) led collaborative efforts among
clinical, biomedical and public health experts to develop the first-ever public health agenda for …

Objective: In a pilot study, participation in the Pathfinders program was associated with
reductions in distress and despair and improvements in quality of life (QOL) among advanced …

… Forecasts evaluated in this analysis are based on submissions in a continuous 79-wk period
starting in late April 2020 and ending in late October 2021 (Fig. 1 and Methods). Forecasts …

Background While curable at early stages, few treatment options exist for advanced melanoma.
Currently, no consensus exists regarding the optimal surveillance strategy for patients …

… 4 April 2016 T Introduction Many clinicians practice palliative care to create a meaningful
difference in the lives of persons with serious illness and their caregivers. Along with the sense …

Tina Ding1, Jo Ledingham2, Raashid Luqmani3, Sarah Westlake4, Kimme Hyrich5, Mark
Lunt5, Patrick Kiely6, Marwan Bukhari7, Rikki Abernethy8, Ailsa Bosworth9, Andrew Ostor10, …